Detalhe da pesquisa
1.
Primary germinal center-resident T follicular helper cells are a physiologically distinct subset of CXCR5hiPD-1hi T follicular helper cells.
Immunity
; 55(2): 272-289.e7, 2022 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35081372
2.
Pivotal Role of Slitrk1 in Adult Striatal Cholinergic Neurons in Mice: Implication in Tourette Syndrome.
Ann Neurol
; 2023 Sep 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37776102
3.
Hidden in plain sight - Survival consequences of baseline symptom burden in women with recurrent ovarian cancer.
Gynecol Oncol
; 185: 128-137, 2024 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38412736
4.
Rates of paclitaxel hypersensitivity reactions using a modified Markman's infusion protocol as primary prophylaxis.
Support Care Cancer
; 32(5): 292, 2024 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38632132
5.
Responses of Early Childhood Educators to Children's Interpersonal Sexual Behaviors.
Arch Sex Behav
; 53(1): 383-394, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37700211
6.
Biomechanical analysis of plate versus K-wire fixation for metacarpal shaft fractures with wedge-shaped bone defects.
BMC Musculoskelet Disord
; 25(1): 350, 2024 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38702748
7.
Mucinous ovarian carcinoma: A survey of practice in Australia and New Zealand.
Aust N Z J Obstet Gynaecol
; 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38299485
8.
Adjuvant chemotherapy following chemoradiotherapy as primary treatment for locally advanced cervical cancer versus chemoradiotherapy alone (OUTBACK): an international, open-label, randomised, phase 3 trial.
Lancet Oncol
; 24(5): 468-482, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37080223
9.
Beta Amyloid Oligomers with Higher Cytotoxicity have Higher Sidechain Dynamics.
Chemistry
; 29(58): e202301879, 2023 Oct 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37706579
10.
A phase I study of the Wee1 kinase inhibitor adavosertib (AZD1775) in combination with chemoradiation in cervical, upper vaginal, and uterine cancers.
Int J Gynecol Cancer
; 33(8): 1208-1214, 2023 08 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37380217
11.
SweetMama: Usability Assessment of a Novel Mobile Application Among Low-Income Pregnant People to Assist With Diabetes Management and Support.
Diabetes Spectr
; 36(2): 171-181, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37193207
12.
Management of Malignant Bowel Obstruction: An Innovative Proactive Outpatient Nurse-Led Model of Care for Patients With Advanced Gynecologic Cancer.
J Nurs Care Qual
; 38(1): 69-75, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36214674
13.
Evidence-based trends and association between symptom disturbance and physical activity among pregnant women: A longitudinal study.
Worldviews Evid Based Nurs
; 20(5): 465-475, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37140131
14.
Self-Assembled Monolayers of Bi-Functionalized Porphyrins: A Novel Class of Hole-Layer-Coordinating Perovskites and Indium Tin Oxide in Inverted Solar Cells.
Angew Chem Int Ed Engl
; 62(40): e202309831, 2023 Oct 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37594921
15.
An Intensive Intervention to Reduce Readmissions for Frequently Hospitalized Patients: the CHAMP Randomized Controlled Trial.
J Gen Intern Med
; 37(8): 1877-1884, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34472021
16.
Measure of Ovarian Symptoms and Treatment concerns (MOST) indexes and their associations with health-related quality of life in recurrent ovarian cancer.
Gynecol Oncol
; 166(2): 254-262, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35718565
17.
Treatment patterns after poly-ADP ribose polymerase (PARP) inhibitors in epithelial ovarian cancer patients.
Int J Gynecol Cancer
; 32(7): 906-912, 2022 07 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35321889
18.
Interobserver and intraobserver variability of RECIST assessment in ovarian cancer.
Int J Gynecol Cancer
; 32(5): 656-661, 2022 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35379690
19.
Getting the MOST out of follow-up: a randomized controlled trial comparing 3 monthly nurse led follow-up via telehealth, including monitoring CA125 and patient reported outcomes using the MOST (Measure of Ovarian Symptoms and Treatment concerns) with routine clinic based or telehealth follow-up, after completion of first line chemotherapy in patients with epithelial ovarian cancer.
Int J Gynecol Cancer
; 32(4): 560-565, 2022 04 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34551895
20.
Symptom burden and quality of life with chemotherapy for recurrent ovarian cancer: the Gynecologic Cancer InterGroup-Symptom Benefit Study.
Int J Gynecol Cancer
; 32(6): 761-768, 2022 06 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35086926